Lytix Biopharma AS is pleased to announce that Dr Øystein Rekdal, CEO in Lytix Biopharma, will give an oral presentation at the `Frontiers in Cancer Immunotherapy 2023′ conference, which is taking place in New York, USA.
Lytix Biopharma AS is pleased to announce that Dr Øystein Rekdal, CEO in Lytix Biopharma, will give an oral presentation at the `Frontiers in Cancer Immunotherapy 2023′ conference, which is taking place in New York, USA.